Similar Items: Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer’s disease: correlation with other biomarkers
- The effect of preanalytical factors on cerebrospinal fluid and plasma proteomics: a systematic experimental study
- Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia
- The design, synthesis and biological evaluation of novel compounds against biomarkers of Alzheimer’s disease
- Mitochondrial homeostasis: the central hub governing the progression of atherosclerosis
- Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery
- From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care